Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls
Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland), Eckart Meese(Saarland University), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Matthias Scheffler(TH Köln - University of Applied Sciences), Anne Borries(BioMed X Institute), Hans‐Peter Lenhof(Saarland University), Hannah Schroers(BioMed X Institute), Julia Lange(Charité - Universitätsmedizin Berlin), Petra Leidinger(Saarland University)
Cited by 368
Related Papers
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
A blood based 12-miRNA signature of Alzheimer disease patients
|Genome biology|2013|514